1011 related articles for article (PubMed ID: 17716385)
1. Mucoactive agents for airway mucus hypersecretory diseases.
Rogers DF
Respir Care; 2007 Sep; 52(9):1176-93; discussion 1193-7. PubMed ID: 17716385
[TBL] [Abstract][Full Text] [Related]
2. The pharmacologic approach to airway clearance: mucoactive agents.
Rubin BK
Respir Care; 2002 Jul; 47(7):818-22. PubMed ID: 12088552
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of new therapies for treatment of mucus hypersecretion in respiratory diseases.
Disse B
Novartis Found Symp; 2002; 248():254-72; discussion 272-6, 277-82. PubMed ID: 12568499
[TBL] [Abstract][Full Text] [Related]
4. Inhaled adrenergics and anticholinergics in obstructive lung disease: do they enhance mucociliary clearance?
Restrepo RD
Respir Care; 2007 Sep; 52(9):1159-73; discussion 1173-5. PubMed ID: 17716384
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the efficacy of mucoactive aerosol therapy.
Fuloria M; Rubin BK
Respir Care; 2000 Jul; 45(7):868-73. PubMed ID: 10926385
[TBL] [Abstract][Full Text] [Related]
6. Mucolytics, expectorants, and mucokinetic medications.
Rubin BK
Respir Care; 2007 Jul; 52(7):859-65. PubMed ID: 17594730
[TBL] [Abstract][Full Text] [Related]
7. Other mucoactive agents for cystic fibrosis.
Bye PT; Elkins MR
Paediatr Respir Rev; 2007 Mar; 8(1):30-9. PubMed ID: 17419976
[TBL] [Abstract][Full Text] [Related]
8. Physiology of airway mucus secretion and pathophysiology of hypersecretion.
Rogers DF
Respir Care; 2007 Sep; 52(9):1134-46; discussion 1146-9. PubMed ID: 17716382
[TBL] [Abstract][Full Text] [Related]
9. Conventional chest physical therapy for obstructive lung disease.
van der Schans CP
Respir Care; 2007 Sep; 52(9):1198-206; discussion 1206-9. PubMed ID: 17716386
[TBL] [Abstract][Full Text] [Related]
10. [Novel approach to respiratory pharmacology--pharmacological basis of cough, sputum and airway clearance].
Miyata T
Yakugaku Zasshi; 2003 Dec; 123(12):987-1006. PubMed ID: 14689863
[TBL] [Abstract][Full Text] [Related]
11. The pharmacologic approach to airway clearance: mucoactive agents.
Rubin BK
Paediatr Respir Rev; 2006; 7 Suppl 1():S215-9. PubMed ID: 16798570
[TBL] [Abstract][Full Text] [Related]
12. Mucolytics in cystic fibrosis.
Henke MO; Ratjen F
Paediatr Respir Rev; 2007 Mar; 8(1):24-9. PubMed ID: 17419975
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of erdosteine in elderly patients with bronchiectasis and hypersecretion: a 15-day, prospective, parallel, open-label, pilot study.
Crisafulli E; Coletti O; Costi S; Zanasi E; Lorenzi C; Lucic S; Fabbri LM; Bertini M; Clini EM
Clin Ther; 2007 Sep; 29(9):2001-9. PubMed ID: 18035199
[TBL] [Abstract][Full Text] [Related]
14. Bronchial mucus transport.
Van der Schans CP
Respir Care; 2007 Sep; 52(9):1150-6; discussion 1156-8. PubMed ID: 17716383
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary mucus: Pediatric perspective.
Rogers DF
Pediatr Pulmonol; 2003 Sep; 36(3):178-88. PubMed ID: 12910578
[TBL] [Abstract][Full Text] [Related]
16. Mucus-controlling agents: past and present.
King M; Rubin BK
Respir Care Clin N Am; 1999 Dec; 5(4):575-94. PubMed ID: 10565882
[TBL] [Abstract][Full Text] [Related]
17. Mucoactive drugs.
Balsamo R; Lanata L; Egan CG
Eur Respir Rev; 2010 Jun; 19(116):127-33. PubMed ID: 20956181
[TBL] [Abstract][Full Text] [Related]
18. Airway mucus hypersecretion in asthma: an undervalued pathology?
Rogers DF
Curr Opin Pharmacol; 2004 Jun; 4(3):241-50. PubMed ID: 15140415
[TBL] [Abstract][Full Text] [Related]
19. Treatment of airway mucus hypersecretion.
Rogers DF; Barnes PJ
Ann Med; 2006; 38(2):116-25. PubMed ID: 16581697
[TBL] [Abstract][Full Text] [Related]
20. [Mucolytics in acute and chronic respiratory tract disorders. I. Pathophysiology and mechanisms of action].
Kupczyk M; Kuna P
Pol Merkur Lekarski; 2002 Mar; 12(69):245-7. PubMed ID: 12053600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
